summary 1. 6-Aminolaevulinate dehydratase activity was measured in liver biopsy specimens from 13 patients with porphyria cutanea tarda, 13 alcoholics and 10 control subjects.
Introduction
Patients with porphyria cutanea tarda (PCT) display marked cutaneous photosensitivity but lack the neurological symptoms which characterize other forms of inherited hepatic porphyrias. PCT is generally a disease of adults and is of sporadic occurrence so that family history can be taken very rarely [l-41. The disease is unique in that an excessive intake of alcohol for a long period of time or administration of oestrogen is required for the development of the symptoms, especially in sporadic cases of PCT. Patients with this disease are characterized biochemically by an increased excretion of uroporphyrin 111, uroporphyrin I and 7-carboxyl porphyrin in urine [5] [6] and their stools may contain a considerable amount of isocoproporphyrin [7] . This disease is associated with deficiency of uroporphyrinogen decarboxylase (EC 4.1.1.37) activity in liver . In a very rare form of familial PCT, the enzymic deficiency may also be found in the erythrocytes [lo-111. At present, it is not known whether the deficiency in hepatic uroporphyrinogen decarboxylase is associated with alterations of enzyme activities in this haem biosynthetic pathway other than 6-aminolaevulinate (ALA) synthase (EC 2.3.1.37).
In the present study, we determined ALA dehydratase (EC 4.2.1.24) activity in liver biopsy specimens and found that it is decreased in the livers of patients with PCT. The decreased activity of ALA dehydratase in the blood in PCT conforms with a recent finding [12] , but in the liver, normal levels of activity have been reported [13] .
We investigated the possibility that the suppression of enzyme activity might be due to the presence of inhibitory factors in the patient's tissues. Firstly, the activity of purified ALA dehydratase was determined before and after addition of the supernatant fraction prepared from the patient's liver. Secondly, enzyme activity was determined after removing heat-labile factors by heat treatment. Thirdly, Zn2+ was added to the enzymic incubation mixture to assess its possible effect on the ALA dehydratase activity. The last test was based on ideas that the utilization of Zn2+ might have been disturbed either by its conjugation with certain unknown substances present in the patient's liver, or by an essential zinc deficiency.
Materials and methods

Patients and sources of the enzyme
The diagnosis of PCT was made on the basis of the typical clinical changes, with bullous photodermatosis, increased skin fragility on face and upper extremities, and increased urinary uroporphyrin ( Table 1 ). All patients were male and heavy alcohol drinkers. Liver specimens were obtained by needle biopsy. All specimens were abnormal on histological examination (Table 2) , and fluoresced by Wood's lamp irradiation. Liver specimens from 10 male non-porphyric, nonalcoholic patients (mean age 42 years, range 27-74 years) were obtained at laparotomies for gastric and duodenal ulcers or gallstones and used as controls. Liver specimens were also obtained from 13 male alcoholic patients (mean age 44 years, range 30-57 years). Alcoholic patients admitted a daily ethanol consumption of more than lOOg for at least 10 years and had resultant social, psychiatric or medical disabilities. All alcoholic patients were not homogeneous in the degree of liver injury. In all cases the biopsies were done with informed consent. Immediately after the biopsy, liver (5-10mg) was homogenized with 2 ml of sucrose solution (0.25 mol/l) containing NaHC03 (0.01 mol/l) and potassium phosphate (0.01 mol/l) buffer, pH 8.0. The homogenate was centrifuged at 48 800g for 30 min at 5"C, and 0.3 ml of the supernatant (containing 0.4-1.0 mg of protein/ml) was used for enzyme assay.
Measurement of ALA dehydratase activity
Hepatic ALA dehydratase activity was assayed by measuring the amount of porphobilinogen formed in 180 min at 37°C in a reaction mixture containing neutralized ALA (5 mmol/l), neutralized dithiothreitol (10 mmol/l) and sodium phosphate (50 mmol/l) buffer, pH 6.8, in a final volume of 0.5 ml. The reaction was terminated by addition of 0.5 ml of trichloroacetic acid (1 mol/l, containing 0.1 mol of HgC12/1). After centrifugation at 3000 g for 5 min, 0.8 ml of the supernatant was taken and mixed with 0.8ml of modified Ehrlich's reagent [containing 8 g of p-dimethylaminobenzaldehyde, 336 ml of acetic acid, 80 ml of perchloric acid and 20 ml of HgClz (0.2 ml/l) in a final volume of about 440 ml]. After 15 min, the absorbance of the Ehrlich-porphobilinogen complex was measured at 553 nm [14] . The above conditions of the reaction were optimum for the assay based on the data which are shown in Fig. 1 .
Hear treatment of the enzyme
Liver supernatant (0.2 ml) was heated for 5 min at 60"C, before the enzyme assay procedure described above. Urinary ALA was determined by the method of Urata & Granick [17] , which was modified as follows: 2nd of urine was applied to a Dowex 5OW-XS column (10 mm x 10 mm, 200-400 mesh, H+ form). The column was washed with distilled water and ALA was subsequently eluted with 3 ml of pyridine (2 mol/l), pH 6.4, and 3 ml of water.
During this elution, aminoketone, which is a monoacid-noncarboxylketone, was retained on the column and was not eluted. To 6 m l of the aliquot was added 0.3 ml of ethyl acetoacetate and the solution was boiled for 10 min to convert ALA to ALA pyrrole. The cooled solution was diluted to 20ml with water and applied to a ALA dehydratase activity was determined as described in the Materials and methods section.
is 64 000 at 553 nm. Table 3) .
Effect of heat treatment and Zn2+. The effect of heat treatment was tested in four out of 13 liver specimens from PCT patients and in 10 normal controls. Heat treatment to the supernatant of liver homogenates from the patients decreased the ALA dehydratase activity slightly (-14%) in the patients studied as well as in the controls (-20.3%) ( Table 3) . Addition of ZnSO, (0.2 mmol/l) did not change the enzyme activity in eight specimens from the PCT patients and two specimens from the controls ( Table 3) .
Kinetic characteristics of ALA dehydratase in liver supernatants from patients with PCT. The apparent K , value of hepatic ALA dehydratase was closely similar for the control subjects and for the PCT patients, being 3.3 x mol/l and 4.3 x moI/I respectively.
Effect of addition of liver supernatants from
PCT patients on the activity of purified bovine liver ALA dehydratase. The activity of a purified preparation of ALA dehydratase was compared before and after mixing with supernatants of liver homogenates from patients with PCT or from control subjects. The results showed that supernatants from both patients and controls did not inhibit the activity of purified ALA dehydratase ( Table 4) .
Effects of uropophyrinogen and iron on ALA dehydratase activity. Uroporphyrinogen and uroporphyrin were added to the purified ALA dehydratase at concentrations comparable with those present in the liver of patients (1-2pg of uro- ALA dehydratase activity in liver of patients with alcoholic liver injury. Hepatic ALA dehydratase activity in alcoholic patients was significantly higher (1 1.5 k4.5) than in PCT patients (8.0 k2.8) (P < 0.05).
Discussion
Our present study demonstrated that the activity of ALA dehydratase was significantly decreased in the livers of patients with PCT.
Heat treatment or addition of Zn2+ to the supernatant of liver had little effect on the enzyme activity in PCT. Addition of Fe2+ or uroporphyrinogen, which is known to be elevated in tissues of PCT patients, did not alter the activity of purified ALA dehydratase. Furthermore, addition of the supernatant of liver from PCT to purified ALA dehydratase did not alter the enzyme activity. These results seem to indicate that decreased activity of ALA dehydratase in liver of PCT patients is due to a decrease in the amount of the enzyme rather than the presence of an inhibitory factor.
Suppression of uroporphyrinogen decarboxylase activity in PCT liver is considered to be a primary enzymic abnormality in this disorder [8-101 which accounts for excessive accumulation and excretion of uroporphyrin or 7-carboxyl porphyrin. Uroporphyrinogen I11 cosynthase activity has been presumed to be low in the livers of PCT patients and is suspected to be inhibited by iron [4, 211. Our present study demonstrates that another cytosolic, haem-synthesizing enzyme (ALA dehydratase) in the liver is decreased in PCT, substantiating the presence of a multienzymic abnormality in this disorder. Since ALA dehydratase is the most abundant of the eight enzymes involved in haem synthesis [22] , and greatly surpasses ALA synthase activity in human liver, reduced ALA dehydratase activity in the PCT liver is considered unlikely to interfere with haem metabolism.
All of our patients with PCT were sporadic cases, the disease very likely being associated with their history of heavy alcohol drinking. Deleterious effects of alcohol on haem metabolism together with a possible inherited metabolic disorder (in non-sporadic PCT) may be involved in several steps in the haem biosynthetic pathway in patients with PCT. It has been reported that the activity of human erythrocyte ALA dehydratase is depressed by alcohol ingestion [23-271. Our study on ALA dehydratase in liver of alcoholics revealed that the level of the enzyme activity was intermediate between those of the control group and PCT, suggesting that excessive alcohol intake in PCT might play a role in reducing the activity of ALA dehydratase.
